Company Analysis

Biote Corp. (BTMD)

Nasdaq: BTMD · Medicinal Chemicals & Botanical Products · Irving, TX · filing with the SEC since 2020
Grade4.8
◀ Past 4.6● Present 4.2▶ Future 5.6

Who runs Biote Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Peterson Robert Charles
Interim CEO. First filing Jan 2024, latest Jun 16, 2026, 2 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
20 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Beer Marc DExecutive ChairmanMay 2022Aug 12, 2026none
Peterson Robert CharlesInterim CEOJan 2024Jun 16, 2026none
Christensen BretChief Executive OfficerFeb 2025Jun 10, 2026none
Heyer Andrew RPresidentMar 2021May 14, 2026none
Monico Daniel MichaelGeneral CounselMay 2026May 4, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Barrera Richard RdirectorFeb 2023May 13, 2026none
Cone Stephen MarkdirectorMay 2022May 13, 2026none
Jacoby Dana LynndirectorMay 2022May 13, 2026none
Morris Debra LdirectorNov 2022May 13, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BTMD · research, not advice